首页> 外国专利> The anti-neoplastic composition having a synergistic effect by combining arsenic compounds and glutathion depleting compounds

The anti-neoplastic composition having a synergistic effect by combining arsenic compounds and glutathion depleting compounds

机译:通过组合砷化合物和消耗谷胱甘肽的化合物具有协同作用的抗肿瘤组合物

摘要

PURPOSE: Provided is an anti-neoplastic composition having a synergistic effect by combining arsenic compounds and glutathione depleting compounds, thereby decreasing the amount of arsenic compound having high toxicity. CONSTITUTION: The anti-neoplastic composition contains arsenic compounds and glutathione depleting compounds in a weight ratio of 1:1-100, and a pharmaceutically acceptable carrier, wherein the arsenic compound is selected from the group consisting of As2O3, As4O6, AsBr3, AsCl3, AsI3 and Melarsoprol; the glutathione depleting compound is selected from the group consisting of Thalidomide, Acetaminophen, Diethyl maleate, Ethacrynic acid, Dimethyl fumarate, Jatrophone, Sesquiterpene lactone, Menadione and BOS(Buthionine Sulphoximine). The glutathione depleting compounds increase the sensitivity of the arsenic compound to cancer cell, therefore, enhances its anti-cancer activity.
机译:用途:提供了一种抗肿瘤组合物,其通过组合砷化合物和消耗谷胱甘肽的化合物而具有协同作用,从而减少了具有高毒性的砷化合物的量。组成:抗肿瘤组合物包含重量比为1:1-100的砷化合物和消耗谷胱甘肽的化合物,以及药学上可接受的载体,其中砷化合物选自As2O3,As4O6,AsBr3,AsCl3, AsI3和美拉s尔;消耗谷胱甘肽的化合物选自沙利度胺,对乙酰氨基酚,马来酸二乙酯,乙炔酸,富马酸二甲酯,麻风树酯,倍半萜内酯,甲萘醌和BOS(花青素磺胺嘧啶)。消耗谷胱甘肽的化合物增加了砷化合物对癌细胞的敏感性,因此增强了其抗癌活性。

著录项

  • 公开/公告号KR20020026743A

    专利类型

  • 公开/公告日2002-04-12

    原文格式PDF

  • 申请/专利权人 LEW YOUNG SUK;NEWGENPHARM CO. LTD.;

    申请/专利号KR20000057987

  • 发明设计人 KIM JAE HO;LEW YOUNG SUK;

    申请日2000-10-02

  • 分类号A61K33/36;

  • 国家 KR

  • 入库时间 2022-08-22 00:31:13

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号